CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in taiwan

Journal of the National Cancer Institute

Volumn 89, Issue 16, 1997, Pages 1207-1212

  Hildesheim, Allan ^a,h   Anderson, Lucy M ^b   Chen, Chien Jen ^c   Cheng, Yu Juen ^c   Brinton, Louise A ^a   Daly, Ann K ^e   Reed, C D ^b   Chen, I How ^f   Caporaso, Neil E ^a   Hsu, Mow Ming ^g   Chen, Jen Yang ^d   Idle, Jeffrey R ^e,i   Hoover, Robert N ^a   Yang, Czau Siung ^d   Chhabra, Saranjit K ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e GenoType Limited   (United Kingdom)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TAIWAN;

EID: 0030749790     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.16.1207     Document Type: Article

References (47)

1. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents. IARC Sci Publ 1992;VI.
2. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993;15:466-85.
3. Hildesheim A, Chen CJ, Caporasu NE, Cheng YJ, Hoover RN, Hsu MM, et al. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 1995;4:607-10.
4. Nouso K, Thorgeirsson SS, Batlula N. Stable expression of human cxtochrome P450IIE1 in mammalian cells: metabolic activation ot nitrosodimethylamine and formation of adducts with cellular DNA. Cancer Res 1992;52: 1796-800.
5. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992;6: 724-30.
6. Andersen LM. Modulation of nitrosamine metabolism by ethanol: implications for cancer risk. In: Watson RR, editor. Alcohol and cancer. Boca Raton (FL): CRC Press, 1992:17-54.
7. Gervasi PG, Longo V, Naldi F, Panattoni G, Ursino F. Xenobiotic-metabolizing enzymes in human respiratory nasal mucosa. Biochem Pharmacol 1991;41:177-84.
8. Longo V, Pacifici GM, Panattoni G, Ursino F, Gervasi PG. Metabolism of diethylnitrosamine by microsomes of human respiratory nasal mucosa and liver. Biochem Pharmacol 1989;38: 1867-9.
9. Smith TJ, Guo Z, Hong JY, Ning SM, Thomas PE, Yang CS. Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis 1992;13:1409-14.
10. Ding XX, Coon MJ. Induction of cytochrome P-450 isozyme 3a (P-450IIE1) in rabbit olfactory mucosa by ethanol and acetone. Drug Metab Dispos 1990;18:742-5.
11. Porter TD, Khani SC, Coon MJ. Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes. Mol Pharmacol 1992;36:61-5.
12. Hayashi SI, Watanabe J, Kawajiri K. Genetic polymorphism in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991;110: 559-65.
13. Watanabe J, Hayashi SI, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem 1994;116: 321-6.
14. Tsutsumi M, Wang JS, Takada A. Hepatic messenger RNA contents of cytochrome P4502E1 in patients with different P4502E1 genotypes. Int Hepatol Commun 1994;2:135-8.
15. Tsutsumi M, Wang JS, Takase S, Takada A. Hepatic P4502E1 expression in human livers with different CYP2E1 genotypes. Hepatology 1994;20(4, Part 2):311A.
16. Carriere V, Berthou F, Baird S, Belloc C, Beaune P, de Waziers I. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 1996;6:203-11.
17. Dai Y, Cederbaum AI. Cvtotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther 1995;273:1497-505.
18. Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H. et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992 ; 52:6712-5.
19. Uematsu F, Kikuchi H, Motomiva M, Abe T, Sagami I, Ohmachi T, et al. Association between restriction fragment length polymorphism of the human cytochrome P4501IE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991;82:254-6.
20. Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P, et al. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 1993;10:447-52.
21. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Vainio H. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 1993;14:85-8.
22. Persson I, Johansson I, Bergling H, Dahl ML, Seidegard J, Rylander R, et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett 1993;3:207-11.
23. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-8.
24. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold, 1982:152-3.
25. Schlesselman JJ. Case-control studies. Design, conduct, and analysis. New York: Oxford University Press, 1982:33-4; 227-90.
26. Breslow NE, Day NE. Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ 1980: 5-338.
27. Yu MC. Diet and nasopharyngeal carcinoma. FEMS Microbiol Immunol 1990;64:235-42.
28. Yu MC. Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ 1991;(105):39-47.
29. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst 1990;82:291-6.
30. Lin TM, Chen KP, Lin CC, Hsu MM, Tu SM, Chiang TC, et al. Retrospective study on nasopharyngeal carcinoma. J Natl Cancer Inst 1973;51:1403-8.
31. West S, Hildesheim A, Dosemeci M. Non-viral risk factor for nasopharyngeal carcinoma in The Philippines: results from a case-control study. Int J Cancer 1993;55:722-7.
32. Mabuchi K, Bross DS, Kessler II. Cigarette smoking and nasopharyngeal carcinoma. Cancer 1985;55:2874-6.
33. Zhu K, Levine RS, Brann EA, Gnepp DR, Baum MK. A population-based case-control study of the relationship between cigarette smoking and nasopharyngeal cancer (United States). Cancer Causes Control 1995;6:507-12.
34. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking, and familial tendency. Anticancer Res 1990;10: 547-53.
35. Nam JM, McLaghlin JK, Blot WJ. Cigarette smoking, alcohol. and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst 1992;84:619-22.
36. Chow WH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer 1993;55:538-40.
37. Yi Z, Ohshima H, Bouvier G, Roy P, Zhonp J, Li B, et al. Urinary excretion of nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for nasopharyngeal carcinoma in southern China. Cancer Epidemiol Biomarkers Prev 1993;2:195-200.
38. Yu MC, Nichols PW, Zou XN, Estes J, Henderson BE. Induction of malignant nasal cavity tumors in Wistar rats fed Chinese salted fish. Br J Cancer 1989;60:198-201.
39. Huang DP, Ho JH, Saw D, Teoh TB. Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish. IARC Sci Publ 1978;(20):315-28.
40. Raucy JL, Kraner JC, Laster JM. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 1993;23: 1-20.
41. Lee CK, Fulp C, Bombict BR, Doolittle DJ. Inhibition of mutagenicity of N-nitrosamines by tobacco smote and its constituents. Mutat Res 1996;367:83-92.
42. Patten CJ, Smith TJ, Tynes RW, Freseu M, Lee T, Yang CS, et al. Evidence for cytochrome P450 2A6 and 3A4 as catalysts for N-nitrosonornicotine alpha hydroxylation in human liver microsomes. Carcinogenesis. In press.
43. Poirier S, Bouvier G, Malaveille C, Ohshima H, Shao YM, Hubert A, et al. Volatile nitrosamine levels and genotoxicity of food samples from high-rist areas for nasopharyngeal carcinoma before and after nitrosation. Int J Cancer 1989;44:1088-94.
44. Poirier S, Ohshima H, de The G, Hubert A, Bourgade MC, Bartsch H. Volatile nitrosamine levels in common food from Tunisia, south China and Greenland, high-rist areas for nasopharyngeal carcinoma (NPC). Int J Cancer 1987;39:293-6.
45. Shao YM. Poirier S, Ohshima H, Malaveille C, Zeng Y, de The G, et al. Epstein-Barr virus activation in Raji cells by extracts of preserved food from high rist areas for nasopharyngeal carcinoma. Carcinogenesis 1988;9:1455-7.
46. Bouvier G, Hergenhahn M, Polack A, Bornkamm GW, de The G, Bartsch H. Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Carcinogenesis 1995;16:1879-85.
47. Chen W, Weisburger JH, Fiala ES, Spratt TE, Carmella SG, Chen D, et al. Gastric carcinogenesis: 2-chloro-4-methylthiobutanoic acid, a novel mutagen in salted, pickled Sanma hiraki fish, or similarly treated methionine. Chem Res Toxicol 1996;9:58-66.